Canadian Plasma Resources (CPR) is a private, for-profit bio-pharmaceutical company and a licensed blood establishment based in Saskatoon, Saskatchewan, Canada.

It was founded in 2012 and specializes in the collection of source plasma for further manufacturing and contract-manufacturing of plasma-based bio-pharmaceuticals with operations in Saskatoon (Saskatchewan), Moncton (New Brunswick), Calgary, Edmonton (Alberta), Winnipeg (Manitoba) and administrative office in Oakville, Ontario.

[4][5] At the request of the government of Ontario,[6] Health Canada organized a public consultation [7] and concluded that donor compensation is not a safety concern.

[14] By that time, CPR had already received strong support from several other Canadian provincial governments [15] citing Canada's over-reliance on other countries with paid donor models for procurement of plasma products.

The panel also found no compelling data to suggest that expansion of source plasma collection – whether with paid or unpaid donors - has negatively impacted the whole blood supply.

Plasma from these operations can only be used for further manufacturing into therapies such as immunoglobulin, human albumin and blood coagulation factors, which are among the World Health Organization's list of essential medicines.